Marco Luís

Mr. Marco Luís

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Gels
Verified
Journal Article
Open access
PDF file
JRJoão Ribeiro
João Ribeiro
MLMarco Luís
Marco Luís
BRBruno Rodrigues
Bruno Rodrigues
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
JMJoana Mesquita
Joana Mesquita
Cândida Teixeira TomazCândida Teixeira Tomaz
Cândida Teixeira Tomaz
The increasing demand for highly pure biopharmaceuticals has put significant pressure on the biotechnological industry to innovate in production and purification processes. Nucleic acid purification, crucial for gene therapy and vaccine production, presents challenges due to the unique physical and chemical properties of these molecules. Meeting regulatory standards necessitates large quantities of biotherapeutic agents of high purity. While conventional chromatography offers versatility and efficiency, it suffers from drawbacks like low flow rates and binding capacity, as well as high mass transfer resistance. Recent advancements in continuous beds, including monoliths and cryogel-based systems, have emerged as promising solutions to overcome these limitations. This review explores and evaluates the latest progress in chromatography utilizing monolithic and cryogenic supports for nucleic acid purification.

14 January 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MLMarco Luís
Marco Luís
MGMarcelo Augusto Damasceno Góes
Marcelo Augusto Damasceno Góes
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
JMJoana Mesquita
Joana Mesquita
PTPaulo Tavares-Ratado
Paulo Tavares-Ratado
Cândida Teixeira TomazCândida Teixeira Tomaz
Cândida Teixeira Tomaz
Monogenic disorders are a group of human diseases caused by mutations in single genes. While some disease-altering treatments offer relief and slow the progression of certain conditions, the majority of monogenic disorders still lack effective therapies. In recent years, gene therapy has appeared as a promising approach for addressing genetic disorders. However, despite advancements in gene manipulation tools and delivery systems, several challenges remain unresolved, including inefficient delivery, lack of sustained expression, immunogenicity, toxicity, capacity limitations, genomic integration risks, and limited tissue specificity. This review provides an overview of the plasmid-based gene therapy techniques and delivery methods currently employed for monogenic diseases, highlighting the challenges they face and exploring potential strategies to overcome these barriers.